Tom Coll

Partner
collta@cooley.com
Full contact info

I represent public and private emerging companies, including leading life sciences companies, on general corporate and transactional matters. I assist clients with corporate, governance, securities, licensing and contractual matters, as well as capital markets and M&A transactional matters. I often work with emerging companies from inception through IPO and beyond. I also work with a number of leading venture capital firms on their investment transactions.

About Tom

Tom Coll's practice covers a broad range of general corporate matters, including counseling public and privately held companies regarding disclosure and reporting requirements, technology licensing, equity incentives, employee compensation and benefits and the formation of new businesses. Tom also represents clients in a broad range of transactional matters, including public offerings, public and private company mergers and acquisitions, corporate partnering and licensing transactions, spin-offs and venture capital financings. He is counsel to public and private companies in a broad range of industries, including biotechnology, medical devices, information storage and wireless communications.

View full bio

Experience

Red Tree Venture Capital – $108 Million Oversubscribed Series B Financing

Red Tree Venture Capital – $108 Million Oversubscribed Series B Financing

March 6, 2023

Cooley advised Red Tree Venture Capital on a $108 million oversubscribed Series B financing – co-led by RA Capital Management – in Bicara Therapeutics, a clinical-stage biotechnology company developing biologics for anti-tumor response.

Related contacts

Terren O'Connor
Associate, San Diego
Arman Sagart
Associate, San Diego
Michelle Hunt
Associate
Tom Coll
Partner, San Diego

Wugen Closes Oversubscribed $172 Million Series B Financing

Wugen Closes Oversubscribed $172 Million Series B Financing

December 12, 2022

Cooley represented Wugen, a clinical-stage biotechnology company developing a pipeline of off-the-shelf cell therapies, on its oversubscribed $172 million Series B financing led by Abingworth and Tybourne Capital Management. Partner Tom Coll led the Cooley team.

Related contacts

Heidi E. Wang
Associate, San Diego
Edmond Lay
Associate, San Diego
Tom Coll
Partner, San Diego

Bright Peak Therapeutics Closes $107 Million Series B Financing

Bright Peak Therapeutics Closes $107 Million Series B Financing

December 12, 2022

Cooley represented Bright Peak Therapeutics, a biotechnology company developing next-generation immunotherapies to treat cancer and autoimmune disease, in its $107 million Series B financing led by RA Capital. Partner Tom Coll led the Cooley team.

Related contacts

Edmond Lay
Associate, San Diego
Heidi E. Wang
Associate, San Diego
Tom Coll
Partner, San Diego

Genomatica Closes $118 Million Series C Financing

Genomatica Closes $118 Million Series C Financing

December 12, 2022

Cooley represented Genomatica, a sustainability leader in the commercialization and expansion of sustainable materials, in its $118 million Series C funding led by Novo Holdings. Partner Tom Coll led the Cooley team.

Related contacts

Edmond Lay
Associate, San Diego
Tom Coll
Partner, San Diego
Sarah Oliai
Associate, Washington DC

Primmune Therapeutics Closes Second Tranche of $8.4 Million Series A Financing

Primmune Therapeutics Closes Second Tranche of $8.4 Million Series A Financing

December 12, 2022

Cooley represented Primmune Therapeutics, a biotechnology company harnessing the power of the innate immune system to treat cancers and viral diseases, in the second tranche of its $8.4 million Series A financing. Partner Tom Coll led the Cooley team.

Related contacts

Edmond Lay
Associate, San Diego
Tom Coll
Partner, San Diego
View more

Rankings & accolades

Chambers USA: Corporate/M&A - California: San Diego (2022)

Best Lawyers in America: Biotechnology Law and Life Sciences, Corporate Law, Leveraged Buyouts and Private Equity Law and Venture Capital Law

Best Lawyers in America: Lawyer of the Year - Leveraged Buyouts and Private Equity Law (2021)

Southern California Super Lawyers: Business/Corporate Law (2007-2014, 2018-2019)

Memberships & affiliations

American Bar Association

San Diego County Bar Association